Biome Diversity Measurement – monitoring the diversity of the human microbiome as an important predictor of the onset of lifestyle diseases and a biomarker of health risks (using AI)

The gut microbiome is a complex ecosystem made up of bacteria, viruses, fungi, and yeasts in our bodies that has a fundamental impact on our health. Currently, there are a number of tests available that focus on analyzing the gut microbiome, which can contribute to improving lifestyle and provide valuable information for optimizing health, especially in the area of nutrition and healthy eating.

Recent research points to the great potential of using gut microbiome testing in clinical practice across a wide range of fields. The microbiome plays a key role in the functioning of our metabolism, immune system, and mental health. Scientific studies describe it as a valuable tool for finding appropriate treatments for autoimmune diseases and for influencing therapy for selected oncological diseases. It is also surprising that monitoring the diversity of the gut microbiome can predict the risk of developing serious lifestyle diseases such as type 1 diabetes, Parkinson’s disease, and Alzheimer’s disease.

In order to be able to use intestinal microbiome testing for such clinically advanced predictions, it is necessary to select sufficiently sensitive technologies for detailed analysis of the representation of microorganisms in the human intestine, repeatedly monitor the diversity of its composition, and validate these results in accordance with current knowledge from clinical practice.

Official press release available here.

ČCZ.01.01.01/01/24_063/0006804 BiDi-Me